TPM2 and colorectal carcinoma: Zhou Y. reported that five genes (BGN, RCN3, TAGLN, MYL9, and TPM2) were identified as fibroblast-specific biomarkers of poorer prognosis of CRC using single-cell multiomics sequencing of FACS-sorted cells isolated from CRC patients [12].